For poorer countries, lack of access to antibiotics worsens resistance
In an article for CIDRAP News, Chris Dall reports about the Access to Medicine Foundation's latest study, titled "Lack of access to medicine is a major driver of drug resistance. How can pharma take action?"
09 June 2022
"Access becomes so under-represented in our discussion about drug resistance that we forget that people are dying from preventable infections even though we have an arsenal of drugs today," the author writes, quoting Jayasree K. Iyer, CEO of the Access to Medicine Foundation.
The article outlines the six case studies featured in the report, as well as its key findings, quoting Fatema Rafiqi, AMR Research Programme Manager at the Foundation: "It was very disturbing to see how few generic medicines actually had any access strategy associated with them. These medicines weren't getting into these low- and middle-income countries, where there was a very dire need."